- Home
- Equipment
- north america
- drug eluting
Show results for
Refine by
Drug Eluting Equipment Supplied In North America
28 equipment items found
Manufactured by:Boston Scientific based inMarlborough, MASSACHUSETTS (USA)
DC Bead is an embolic Drug-Eluting Bead capable of loading and releasing in a controlled manner chemotherapeutic agents. DC Bead is used in trans-arterial chemoembolisation (TACE). This is a minimally invasive (non-surgical) procedure performed by an interventional ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
The DynamX Drug Eluting Coronary Bioadaptor System is a significant innovation in the treatment of coronary artery disease. Going beyond drug-eluting stents (DES), DynamX represents one of the most significant breakthroughs in implant design in the past 30 ...
Manufactured by:Invamed based inChampionsGate, FLORIDA (USA)
Atlas is a coronary balloon-expandable CoCr (L605) stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery ...
Manufactured by:Invamed based inChampionsGate, FLORIDA (USA)
Atlas? is a coronary balloon-expandable Stainless Steel stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery disease – including acute coronary syndrome acute myocardial infarction or unstable angina and/or concomitant diabetes mellitus – to improve luminal diameter and reduce restenosis within ...
Manufactured by:Boston Scientific based inMarlborough, MASSACHUSETTS (USA)
Effective at penetrating metastatic tumors and avoiding premature proximal occlusion of tumour-feeding vessels. May allow for more concentrated drug delivery within the tumour and greater tumoural devascularisation. May allow the doctor to be more selective and target only the vessels feeding the tumour and so protect the healthy liver and reduce stress to cirrhotic liver. Allows ...
Manufactured by:Medinol based inTel Aviv, ISRAEL
From crimping through delivery through calcified lesions, expansion and drug elution, drug-eluting stents endure substantial mechanical and chemical stress. Inherently brittle, traditional polymer coatings of drug eluting stents have been shown to develop surface imperfections and deformations, ...
by:Tryton Medical, Inc. based inDurham, NORTH CAROLINA (USA)
The Tryton Side Branch Stent is deployed in the side branch artery using a standard single-wire, balloon-expandable stent delivery system. The open architecture of the Tryton stent allows for integration of a conventional drug eluting stent for the main ...
Manufactured by:Nordson Medical based inHuntington Beach, CALIFORNIA (USA)
These constructions can also increase performance and possibly reduce overall assembly and material costs, making the medical device more cost effective for the customer. Other key functionalities may include active material layers, such as hydrophilic, bioresorbable, or drug-eluting layers. The technology and materials now used to produce multi-layer products ...
Manufactured by:Medinol based inTel Aviv, ISRAEL
WiZeCell, our proprietary stent design is paradigm shift in cardiovascular stenting. The design’s sixth generation, the EluNIR drug eluting stent, relieves physicians from compromising between vessel conformability, scaffolding integrity, uniform drug distribution and radial support by offering an integrated design maximizing all benefits ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
Novolimus is a metabolite of the drug Sirolimus, a novel mTOR inhibitor macrolytic lactone with anti-proliferative and anti-inflammatory properties developed by Elixir Medical. The macrocyclic lactone drugs represent the most widely utilized drug family for drug-eluting stent applications and have an established ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
Sirolimus is the most widely known mTOR inhibitor with a well-established safety and effectiveness profile in various treatment applications: Drug-eluting stents, Transplant, Oncology. Novolimus and Sirolimus have been studied as part of Elixir Medical’s Clinical Programs. These clinical trials for DynamX™, DESyne®, DESyne® BD and the ...
Manufactured by:Medinol based inTel Aviv, ISRAEL
Flexx² is based on a tapered spring tip designed to eliminate tip flare out and buckling while enabling simultaneous flexibility and pushability. The entire coronary product line of Medinol builds on Flexx² catheters, including the EluNIR drug eluting stent system and the NC Gallant PTCA ...
Manufactured by:Becton Dickinson and Company (BD) based inFranklin Lakes, NEW JERSEY (USA)
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late stent thrombosis with current DESs. In addition, Tepha is developing fully absorbable polymer stents containing TephaFLEX® material, which would ...
Manufactured by:CeloNova BioSciences, Inc. based inCarlsbad, CALIFORNIA (USA)
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...
Manufactured by:Exogenesis Corporation based inBillerica, MASSACHUSETTS (USA)
NanoAccel’s platform technology employs a technology known as gas cluster ion beam (GCIB). Pressurized argon gas, used due to its inert properties, is expanded through a small nozzle into vacuum to form a beam of gas clusters. Each cluster is comprised of several hundred to a few thousand weakly bound atoms. The clusters are caused to become electrically charged and they are then ...
Manufactured by:Exogenesis Corporation based inBillerica, MASSACHUSETTS (USA)
Exogenesis has created a new NanoAccel technology known as accelerated neutral atom beam (ANAB). NanoAccell is used for ultra-shallow processing of surfaces used for biomedical applications, for optical components, for semiconductor devices, and for other nanosurface modified products. In ANAB, a beam of accelerated gas cluster ions is initially produced as described in GCIB, but the gas cluster ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. and effective across a broad spectrum of patient and lesion complexity. ...
Manufactured by:OrbusNeich Medical Company Ltd. based inShatin, N.T., CHINA
The Pro-Healing DES Designed for rapid vessel healing and superior clinical ...
Manufactured by:Lyra Therapeutics, Inc. based inWatertown, MASSACHUSETTS (USA)
LYR-220, Lyra’s second product candidate, is in Phase 2 development for the millions of chronic rhinosinusitis (CRS) patients who have undergone a prior sinus surgery but continue to have persistent ...
Manufactured by:Freudenberg Medical based inCarpinteria, CALIFORNIA (USA)
A variety of specialized materials are being used in today’s MedTech environment. Many of these materials are only made suitable for the intended finished use by applying a customized surface treatment. These treatments can result in reduced friction, improvement of haptic properties, the introduction of chemical functionalities, and improved medium resistance of the materials. To meet ...